Virtus Investment Advisers’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$95.9K Sell
4,783
-2,359
-33% -$47.3K 0.03% 350
2025
Q1
$141K Buy
+7,142
New +$141K 0.04% 352